These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20440542)

  • 1. Functionality of unliganded VDR in breast cancer cells: repressive action on CYP24 basal transcription.
    Alimirah F; Vaishnav A; McCormick M; Echchgadda I; Chatterjee B; Mehta RG; Peng X
    Mol Cell Biochem; 2010 Sep; 342(1-2):143-50. PubMed ID: 20440542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of vitamin D receptor binding sites defines the different vitamin D responsiveness of the CYP24 gene in malignant and normal mammary cells.
    Matilainen JM; Malinen M; Turunen MM; Carlberg C; Väisänen S
    J Biol Chem; 2010 Jul; 285(31):24174-83. PubMed ID: 20460683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1.
    Dwivedi PP; Muscat GE; Bailey PJ; Omdahl JL; May BK
    J Mol Endocrinol; 1998 Jun; 20(3):327-35. PubMed ID: 9687155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer.
    Mimori K; Tanaka Y; Yoshinaga K; Masuda T; Yamashita K; Okamoto M; Inoue H; Mori M
    Ann Oncol; 2004 Feb; 15(2):236-41. PubMed ID: 14760115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
    Anderson PH; O'Loughlin PD; May BK; Morris HA
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2.
    Cui M; Zhao Y; Hance KW; Shao A; Wood RJ; Fleet JC
    J Cell Physiol; 2009 Apr; 219(1):132-42. PubMed ID: 19097033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2.
    Cui M; Klopot A; Jiang Y; Fleet JC
    J Cell Physiol; 2009 Jan; 218(1):113-21. PubMed ID: 18726998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells.
    Peng X; Tiwari N; Roy S; Yuan L; Murillo G; Mehta RR; Benya RV; Mehta RG
    J Endocrinol; 2012 Feb; 212(2):207-15. PubMed ID: 22068926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels.
    Anderson PH; O'Loughlin PD; May BK; Morris HA
    Bone; 2005 Apr; 36(4):654-62. PubMed ID: 15781002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
    Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
    J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid augments vitamin D receptor-mediated induction of CYP24 by vitamin D3: a possible cause of valproic acid-induced osteomalacia?
    Vrzal R; Doricakova A; Novotna A; Bachleda P; Bitman M; Pavek P; Dvorak Z
    Toxicol Lett; 2011 Feb; 200(3):146-53. PubMed ID: 21115105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
    Peräkylä M; Malinen M; Herzig KH; Carlberg C
    Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells.
    Valrance ME; Brunet AH; Acosta A; Welsh J
    J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation.
    Alimirah F; Peng X; Yuan L; Mehta RR; von Knethen A; Choubey D; Mehta RG
    Exp Cell Res; 2012 Nov; 318(19):2490-7. PubMed ID: 22884583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3.
    Väisänen S; Dunlop TW; Sinkkonen L; Frank C; Carlberg C
    J Mol Biol; 2005 Jul; 350(1):65-77. PubMed ID: 15919092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells.
    Alimirah F; Peng X; Murillo G; Mehta RG
    PLoS One; 2011 Jan; 6(1):e16024. PubMed ID: 21283672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase- polymerase chain reaction.
    Anderson PH; O'Loughlin PD; May BK; Morris HA
    J Mol Endocrinol; 2003 Aug; 31(1):123-32. PubMed ID: 12914530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.